News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
108last 24h
3128last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Investing.com2d agobullish
Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugsInvestor's Business Daily2d agobullish
Hims & Hers Surges On 'Surprising And Inevitable' Deal With Eli LillyBarrons.com2d agoneutral
Why Hims & Hers Health Stock Was in Dire Need of This Eli Lilly AgreementGuruFocus.com4d agobullish
Novo Nordisk AS (NVO) (Q3 2026) Earnings Call Highlights: Obesity Sales Surge 22% as Wegovy ...GuruFocus.com4d agoneutral
Novo Nordisk Stocks Rise 5.65% While Higher Guidance Meets Diverging Profit MeasuresYahoo Finance4d agoneutral
Novo Nordisk CEO says CVS breakup has no material impact on the weight-loss drug giantMT Newswires4d agobullish
European Stocks Rally in Wednesday Trading Following US Elections; Euro Area Inflation RisesInvestor's Business Daily4d agobullish
Novo Surges 6% After Walloping Expectations On The Back Of Its GLP-1 DrugsBarrons.com4d agoneutral
Novo Nordisk Stock Shrugs Off Eli Lilly Threat as Weight-Loss Pill Shines in EarningsInvestor's Business Daily4d agobullish
Novo Surges 5% After Walloping Expectations On The Back Of Its GLP-1 DrugsBarrons.com4d agoneutral
Pfizer CEO Bourla Bets the Viagra Playbook Can Crack the Obesity Market